A qualitative and quantitative review of cocaine-induced craving: The phenomenon of priming

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 31, Issue 3, 2007, Pages 593-599

  Mahoney III, James J ^a   Kalechstein, Ari D ^a   De La Garza II, Richard ^a   Newton, Thomas F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cocaine; Craving; Priming; Reinstatement; Relapse

Indexed keywords

COCAINE;

CORRELATION ANALYSIS; DATA ANALYSIS; EFFECT SIZE; HUMAN; PRIMING; PROBABILITY; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RELAPSE; REVIEW; RISK ASSESSMENT; RISK FACTOR; WITHDRAWAL SYNDROME;

BEHAVIOR, ADDICTIVE; COCAINE; COCAINE-RELATED DISORDERS; DATABASES, FACTUAL; DOPAMINE UPTAKE INHIBITORS; HUMANS; META-ANALYSIS; PUBMED;

EID: 33947516239     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2006.12.004     Document Type: Review

References (57)

1. Cohen J. Statistical power analysis for the behavioral science. 2 ed. (1988), L. Erlbaum Associates, Hillsdale, N.J.
2. Collins E.D., Ward A.S., McDowell D.M., Foltin R.W., and Fischman M.W. The effects of memantine on the subjective, reinforcing and cardiovascular effects of cocaine in humans. Behav Pharmacol 9 7 (1998) 587-598
3. De La Garza II R., Newton T.F., and Kalechstein A.D. Risperidone diminishes cocaine-induced craving. Psychopharmacology (Berl) 178 2-3 (2005) 347-350
4. de Wit H. Priming effects with drugs and other reinforcers. Exp Clin Psychopharmacol 4 1 (1996) 5-10
5. Donny E.C., Bigelow G.E., and Walsh S.L. Choosing to take cocaine in the human laboratory: effects of cocaine dose, inter-choice interval, and magnitude of alternative reinforcement. Drug Alcohol Depend 69 3 (2003) 289-301
6. Donny E.C., Bigelow G.E., and Walsh S.L. Assessing the initiation of cocaine self-administration in humans during abstinence: effects of dose, alternative reinforcement, and priming. Psychopharmacology (Berl) 172 3 (2004) 316-323
7. Donny E.C., Bigelow G.E., and Walsh S.L. Comparing the physiological and subjective effects of self-administered vs yoked cocaine in humans. Psychopharmacology (Berl) 186 4 (2006) 544-552
8. Edwards S., Whisler K.N., Fuller D.C., Orsulak P.J., and Self D.W. Addiction-related alterations in d(1) and d(2) dopamine receptor behavioral responses following chronic cocaine self-administration. Neuropsychopharmacology (2006)
9. Fischman M.W., Foltin R.W., Nestadt G., and Pearlson G.D. Effects of desipramine maintenance on cocaine self-administration by humans. J Pharmacol Exp Ther 253 2 (1990) 760-770
10. Foltin R.W., and Haney M. Conditioned effects of environmental stimuli paired with smoked cocaine in humans. Psychopharmacology (Berl) 149 1 (2000) 24-33
11. Foltin R.W., and Haney M. Intranasal cocaine in humans: acute tolerance, cardiovascular and subjective effects. Pharmacol Biochem Behav 78 1 (2004) 93-101
12. Foltin R.W., Ward A.S., Collins E.D., Haney M., Hart C.L., and Fischman M.W. The effects of venlafaxine on the subjective, reinforcing, and cardiovascular effects of cocaine in opioid-dependent and non-opioid-dependent humans. Exp Clin Psychopharmacol 11 2 (2003) 123-130
13. Haney M., Foltin R.W., and Fischman M.W. Effects of pergolide on intravenous cocaine self-administration in men and women. Psychopharmacology (Berl) 137 1 (1998) 15-24
14. Haney M., Collins E.D., Ward A.S., Foltin R.W., and Fischman M.W. Effect of a selective dopamine d1 agonist (abt-431) on smoked cocaine self-administration in humans. Psychopharmacology (Berl) 143 1 (1999) 102-110
15. Haney M., Ward A.S., Foltin R.W., and Fischman M.W. Effects of ecopipam, a selective dopamine d1 antagonist, on smoked cocaine self-administration by humans. Psychopharmacology (Berl) 155 4 (2001) 330-337
16. Haney M., Hart C., Collins E.D., and Foltin R.W. Smoked cocaine discrimination in humans: effects of gabapentin. Drug Alcohol Depend 80 1 (2005) 53-61
17. Haney M., Hart C.L., and Foltin R.W. Effects of baclofen on cocaine self-administration: opioid- and nonopioid-dependent volunteers. Neuropsychopharmacology (2006)
18. Hart C.L., Ward A.S., Collins E.D., Haney M., and Foltin R.W. Gabapentin maintenance decreases smoked cocaine-related subjective effects, but not self-administration by humans. Drug Alcohol Depend 73 3 (2004) 279-287
19. Houtsmuller E.J., Notes L.D., Newton T., van Sluis N., Chiang N., Elkashef A., et al. Transdermal selegiline and intravenous cocaine: safety and interactions. Psychopharmacology (Berl) 172 1 (2004) 31-40
20. Jaffe J.H., Cascella N.G., Kumor K.M., and Sherer M.A. Cocaine-induced cocaine craving. Psychopharmacology (Berl) 97 1 (1989) 59-64
21. Jeffcoat A.R., Perez-Reyes M., Hill J.M., Sadler B.M., and Cook C.E. Cocaine disposition in humans after intravenous injection, nasal insufflation (snorting), or smoking. Drug Metab Dispos 17 2 (1989) 153-159
22. Johanson C.E., Lundahl L.H., Lockhart N., and Schubiner H. Intravenous cocaine discrimination in humans. Exp Clin Psychopharmacol 14 2 (2006) 99-108
23. Johnson B.A., Roache J.D., Ait-Daoud N., Wells L.T., and Mauldin J.B. Effects of isradipine on cocaine-induced subjective mood. J Clin Psychopharmacol 24 2 (2004) 180-191
24. Kosten T., Gawin F.H., Silverman D.G., Fleming J., Compton M., Jatlow P., et al. Intravenous cocaine challenges during desipramine maintenance. Neuropsychopharmacology 7 3 (1992) 169-176
25. Kouri E.M., Lundahl L.H., Borden K.N., McNeil J.F., and Lukas S.E. Effects of oral contraceptives on acute cocaine response in female volunteers. Pharmacol Biochem Behav 74 1 (2002) 173-180
26. Leri F., and Stewart J. The consequences of different "lapses" on relapse to heroin seeking in rats. Exp Clin Psychopharmacol 10 4 (2002) 339-349
27. Leyton M., Casey K.F., Delaney J.S., Kolivakis T., and Benkelfat C. Cocaine craving, euphoria, and self-administration: a preliminary study of the effect of catecholamine precursor depletion. Behav Neurosci 119 6 (2005) 1619-1627
28. Lile J.A. Pharmacological determinants of the reinforcing effects of psychostimulants: relation to agonist substitution treatment. Exp Clin Psychopharmacol 14 1 (2006) 20-33
29. Muntaner C., Cascella N.G., Kumor K.M., Nagoshi C., Herning R., and Jaffe J. Placebo responses to cocaine administration in humans: effects of prior administrations and verbal instructions. Psychopharmacology (Berl) 99 2 (1989) 282-286
30. Nann-Vernotica E., Donny E.C., Bigelow G.E., and Walsh S.L. Repeated administration of the d1/5 antagonist ecopipam fails to attenuate the subjective effects of cocaine. Psychopharmacology (Berl) 155 4 (2001) 338-347
31. Nelson R.A., Boyd S.J., Ziegelstein R.C., Herning R., Cadet J.L., Henningfield J.E., et al. Effect of rate of administration on subjective and physiological effects of intravenous cocaine in humans. Drug Alcohol Depend 82 1 (2006) 19-24
32. Newton T.F., Kalechstein A.D., De La Garza II R., Cutting D.J., and Ling W. Apathy predicts hedonic but not craving response to cocaine. Pharmacol Biochem Behav 82 1 (2005) 236-240
33. Pedhazur E.J., and Schmelkin L.P. Measurement, design, and analysis: an integrated approach (student ed.) (1991), Lawrence Erlbaum Associates, Inc., Hillsdale, NJ, USA
34. Preston K.L., Sullivan J.T., Strain E.C., and Bigelow G.E. Effects of cocaine alone and in combination with bromocriptine in human cocaine abusers. J Pharmacol Exp Ther 262 1 (1992) 279-291
35. Preston K.L., Sullivan J.T., Berger P., and Bigelow G.E. Effects of cocaine alone and in combination with mazindol in human cocaine abusers. J Pharmacol Exp Ther 267 1 (1993) 296-307
36. Randich A., and LoLordo V.M. Associative and nonassociative theories of the ucs preexposure phenomenon: implications for pavlovian conditioning. Psychol Bull 86 3 (1979) 523-548
37. Roache J.D., Johnson B.A., Ait-Daoud N., Mauldin J.B., Thornton J.E., Wells L.T., et al. Effects of repeated-dose isradipine on the abuse liability of cocaine. Exp Clin Psychopharmacol 13 4 (2005) 319-326
38. Robbins S.J., Ehrman R.N., Childress A.R., and O'Brien C.P. Relationships among physiological and self-report responses produced by cocaine-related cues. Addict Behav 22 2 (1997) 157-167
39. Romach M.K., Glue P., Kampman K., Kaplan H.L., Somer G.R., Poole S., et al. Attenuation of the euphoric effects of cocaine by the dopamine d1/d5 antagonist ecopipam (sch 39166). Arch Gen Psychiatry 56 12 (1999) 1101-1106
40. Rosenthal R. Meta-analytic procedures for social research (Rev. ed.) (1991), Sage publications, Newbury Park
41. Rush C.R., Baker R.W., and Wright K. Acute physiological and behavioral effects of oral cocaine in humans: a dose-response analysis. Drug Alcohol Depend 55 1-2 (1999) 1-12
42. Saladin M.E. Us preexposures retard excitatory and facilitate inhibitory conditioning of the rabbit's nictitating membrane response. Anim Learn Behav 14 2 (1986) 121-132
43. Samaha A.N., and Robinson T.E. Why does the rapid delivery of drugs to the brain promote addiction?. Trends Pharmacol Sci 26 2 (2005) 82-87
44. Samaha A.N., Mallet N., Ferguson S.M., Gonon F., and Robinson T.E. The rate of cocaine administration alters gene regulation and behavioral plasticity: implications for addiction. J Neurosci 24 28 (2004) 6362-6370
45. Sofuoglu M., Pentel P.R., Bliss R.L., Goldman A.I., and Hatsukami D.K. Effects of phenytoin on cocaine self-administration in humans. Drug Alcohol Depend 53 3 (1999) 273-275
46. Sofuoglu M., Brown S., Babb D.A., Pentel P.R., and Hatsukami D.K. Carvedilol affects the physiological and behavioral response to smoked cocaine in humans. Drug Alcohol Depend 60 1 (2000) 69-76
47. Sofuoglu M., Brown S., Babb D.A., Pentel P.R., and Hatsukami D.K. Effects of labetalol treatment on the physiological and subjective response to smoked cocaine. Pharmacol Biochem Behav 65 2 (2000) 255-259
48. Sofuoglu M., Dudish-Poulsen S., Brown S.B., and Hatsukami D.K. Association of cocaine withdrawal symptoms with more severe dependence and enhanced subjective response to cocaine. Drug Alcohol Depend 69 3 (2003) 273-282
49. Sofuoglu M., Poling J., Mitchell E., and Kosten T.R. Tiagabine affects the subjective responses to cocaine in humans. Pharmacol Biochem Behav 82 3 (2005) 569-573
50. Sughondhabirom A., Jain D., Gueorguieva R., Coric V., Berman R., Lynch W.J., et al. A paradigm to investigate the self-regulation of cocaine administration in humans. Psychopharmacology (Berl) 180 3 (2005) 436-446
51. Tiffany S.T., and Drobes D.J. The development and initial validation of a questionnaire on smoking urges. Br J Addict 86 11 (1991) 1467-1476
52. Tiffany S.T., Singleton E., Haertzen C.A., and Henningfield J.E. The development of a cocaine craving questionnaire. Drug Alcohol Depend 34 1 (1993) 19-28
53. Walsh S.L., Haberny K.A., and Bigelow G.E. Modulation of intravenous cocaine effects by chronic oral cocaine in humans. Psychopharmacology (Berl) 150 4 (2000) 361-373
54. Ward A.S., Collins E.D., Haney M., Foltin R.W., and Fischman M.W. Ketoconazole attenuates the cortisol response but not the subjective effects of smoked cocaine in humans. Behav Pharmacol 9 7 (1998) 577-586
55. Ward A.S., Haney M., Fischman M.W., and Foltin R.W. Binge cocaine self-administration in humans: intravenous cocaine. Psychopharmacology (Berl) 132 4 (1997) 375-381
56. Ward A.S., Haney M., Fischman M.W., and Foltin R.W. Binge cocaine self-administration by humans: smoked cocaine. Behav Pharmacol 8 8 (1997) 736-744
57. Winhusen T., Somoza E., Singal B.M., Harrer J., Apparaju S., Mezinskis J., et al. Methylphenidate and cocaine: a placebo-controlled drug interaction study. Pharmacol Biochem Behav (2006)